Wuhan Optics Valley Vcanbiopharma Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Wuhan Optics Valley Vcanbiopharma Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) Treatment (NCT06677255) | Wuhan Optics Valley Vcanbiopharma Co., Ltd. | 2025-01-01 |
| Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF) (NCT06230822) | Wuhan Optics Valley Vcanbiopharma Co., Ltd. | 2024-03-05 |
Track Wuhan Optics Valley Vcanbiopharma Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.